SK
Sanjeev Kumar Sethi
About Sanjeev Kumar Sethi
Data last updated:
Sanjeev Kumar Sethi has 18 years in corporate governance. Holds Additional Director and Director roles. Currently with 5 companies, including Agila Specialties Private Limited and Onco Therapies Limited. Formerly with 6 companies, such as Smv Promoters Llp and Famy Life Sciences Private Limited. Engaged in General Business, Healthcare. Contributes to corporate operations. The 4 current companies with reported revenue have a combined latest revenue of ₹206 Cr; the largest is Aizant Drug Research Solutions Private Limited at ₹193 Cr (FY 2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Aizant Drug Research Solutions Private Limited U24239TG2005PTC048133 | Director | 30 Sep 2024 | 2005 | ₹193 Cr (FY 2023) | Active |
 Psmr Consulting Llp ACJ-8877 | Designated Partner | 11 Oct 2024 | 2024 | ₹13.33 Cr (FY 2026) | Active |
| Astrel Genome Limited U24230TG2005PLC045301 | Additional Director | 15 Feb 2025 | 2005 | ₹0.22 Cr (FY 2025) | Active |
| Council For Healthcare And Pharma Front U85300DL2018NPL332759 | Director | 19 Apr 2018 | 2018 | ₹0.00 Cr (FY 2025) | Active |
| Partner | 12 Jul 2023 | 2020 | – | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Smv Promoters Llp ACA-8255 | Designated Partner | 27 Apr 2023 | 2023 | – | Active |
 Famy Life Sciences Private Limited U40109TS2008PTC188720 | Nominee Director | 09 Jan 2020 | 2008 | ₹2.36 Cr (FY 2025) | Active |
 Mylan Laboratories Limited U24231TG1984PLC005146 | Director | 07 Oct 2009 | 1984 | ₹7,504 Cr (FY 2025) | Active |
 Mylan Pharmaceuticals Private Limited U73100TG1997PTC149781 | Whole-Time Director | 28 Mar 2008 | 1997 | ₹1,253 Cr (FY 2025) | Active |
| Agila Specialties Private Limited U02429TG2004PTC093829 | Additional Director | 05 Dec 2013 | 2004 | – | Amalgamated |
| Onco Therapies Limited U24232TG2007PLC093716 | Additional Director | 05 Dec 2013 | 2007 | – | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sanjeev Kumar Sethi
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sanjeev Kumar Sethi
Sanjeev Kumar Sethi has 18 years in corporate governance. Holds Additional Director and Director roles. Currently with 5 companies, including Agila Specialties Private Limited and Onco Therapies Limited. Formerly with 6 companies, such as Smv Promoters Llp and Famy Life Sciences Private Limited. Engaged in General Business, Healthcare. Contributes to corporate operations. The 4 current companies with reported revenue have a combined latest revenue of ₹206 Cr; the largest is Aizant Drug Research Solutions Private Limited at ₹193 Cr (FY 2023).
Sanjeev Kumar Sethi is associated with 5 companies as Additional Director and Director, including Aizant Drug Research Solutions Private Limited (₹193 Cr), Psmr Consulting Llp (₹13.33 Cr), Astrel Genome Limited (₹0.22 Cr).
Sanjeev Kumar Sethi has expertise in General Business, Healthcare.
Sanjeev Kumar Sethi has 18 years in corporate governance.
By reported revenue, the largest current company of Sanjeev Kumar Sethi is Aizant Drug Research Solutions Private Limited, with revenue of ₹193 Cr (FY 2023).
The 4 current companies of Sanjeev Kumar Sethi that report revenue have a combined latest revenue of ₹206 Cr.
Sanjeev Kumar Sethi currently holds positions at 5 companies: Aizant Drug Research Solutions Private Limited (₹193 Cr), Psmr Consulting Llp (₹13.33 Cr), Astrel Genome Limited (₹0.22 Cr), Council For Healthcare And Pharma Front (₹0.00 Cr), Lakshmi Consulting Bureau Services Llp.